African Centre of Excellence for Genomics of Infectious Diseases
The African Centre of Excellence for Genomics of Infectious Diseases (ACEGID) is Nigeria’s first genomics research lab—advancing the continent’s ability to detect, contain, and prevent future epidemics.
Led by Dr. Christian Happi and Dr. Pardis Sabeti, ACEGID played a pivotal role in halting the spread of Ebola in Lagos in 2014 by enabling a rapid response that protected a city of over 20 million. In partnership with the Broad Institute and MASS, ACEGID expanded its impact through the completion of a purpose-built genomics laboratory in Ede, Nigeria. The facility includes a biosafety level 3 (BSL-3) lab—one of the first of its kind in West Africa—enabling researchers to safely handle and study some of the world’s most dangerous pathogens using cutting-edge technology.
Beyond research, the center strengthens long-term scientific capacity by training a new generation of African scientists in genomics-based tools to combat infectious diseases. It also contributes to a global bio-surveillance network monitoring emerging health threats. The building’s integrated layout—featuring labs, classrooms, offices, and shared spaces—was designed to foster collaboration across disciplines, institutions, and borders.
Architecturally, the project demonstrates how locally sourced, sustainable materials—such as stabilized rammed earth—can support high-performance research environments. It stands as a model for blending advanced science infrastructure with local construction practices.
At the onset of the COVID-19 pandemic, ACEGID mapped Africa’s first SARS-CoV-2 genome sequence and has continued to provide critical public health information and national support. With this new facility, ACEGID further strengthens its leadership in epidemic preparedness and global health equity.
